Leishmaniasis, cutaneous leishmaniasis
ICD-10 B56.0 is a billable code used to indicate a diagnosis of leishmaniasis, cutaneous leishmaniasis.
Cutaneous leishmaniasis is a parasitic infection caused by protozoa of the genus Leishmania, transmitted through the bite of infected sandflies. This condition is characterized by skin lesions that can vary in appearance from papules to ulcers, often leading to significant morbidity due to disfigurement and secondary infections. The lesions typically appear weeks to months after the initial bite and can be localized or disseminated. Diagnosis is primarily clinical, supported by laboratory tests such as skin scrapings or biopsies to identify the parasite. Treatment options include topical therapies, such as paromomycin or imiquimod, and systemic therapies like pentavalent antimonials or amphotericin B for more severe cases. The disease is endemic in tropical and subtropical regions, making awareness and accurate coding essential for effective management and epidemiological tracking.
Detailed patient history, including travel and exposure history, laboratory results, and treatment plans.
Patients presenting with skin lesions after travel to endemic areas.
Consideration of co-infections and the need for multidisciplinary management.
Photographic evidence of lesions, detailed descriptions of lesion morphology, and treatment response.
Patients with chronic skin ulcers or lesions that do not respond to standard treatments.
Differentiating from other dermatological conditions such as cutaneous sarcoidosis or leprosy.
Used when a biopsy is performed to confirm leishmaniasis.
Biopsy report and clinical notes detailing the lesion.
Dermatology may require additional imaging or follow-up.
Common symptoms include skin lesions that may appear as papules or ulcers, often accompanied by itching or pain. Lesions can take weeks to months to develop after the initial sandfly bite.
